IJPR  articles are Indexed in SCOPUS (2010 - 2021)Click Here     *Five Years Citation in Google scholar (2016 - 2020) is. 1451*        Now IJPR is Q2 in SJR Ranking     Scopus Coverage of IJPR (2010-2021 Issue 1)            

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Antineoplastic Marine Secondary Metabolites: Drugs, Drug-Candidates Under Clinical Trials, and Scaffolds of Potential Anticancer Activity

Author: ABDEL-NASSER EL-SHORBAGI, SACHIN CHAUDHARY, ALAA ALI ALJARAD, ESRAA OMER, FATMA MAHMOUD, RAMESH KUMAR GUPTA, AMIT KUMAR, MAHMOUD H. MOHAMED
Abstract: Marine environment is among the substantial sources of biologically active agents that own diverse pharmacological properties such as radical scavenging, anti-cancer, antimicrobial, antiviral and analgesic activities. Marine metabolites are considered as an alternative source to meet the demand for effective safe and low-cost drugs. Cancer is one of the leading causes of death in the world. Despite notable developments in cancer treatment in the past decades, there remains an urgent need for innovative drugs in the field of cancer biology, particularly from the less explored area of marine-potential-anticancer compounds. Nevertheless, new technological innovations in the detection of the structure, the semi-synthetic and synthetic preparation of the new compounds. Biological assays facilitate isolation and clinical evaluation of numerous unique anti-cancer compounds from the marine environment. This review gives a general summary about marine natural products (MNPs) as anti-cancer agents and describes their mechanisms of action in addition to drug-candidates under clinical trial phases (I-III) with their current status has also been enlisted.
Keyword: Marine drugs, Cancer, Antiviral, Analgesic, Clinical trial.
DOI: https://doi.org/10.31838/ijpr/2021.13.02.205
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free